Abstract
A possible future influenza A pandemic similar to the 1918 H1N1 outbreak remains an existential public health threat. A universal influenza A vaccine that protects regardless of hemagluttinin (H) and neuraminidase (N) subgroups remains elusive. The influenza genome encodes for a few proteins highly conserved among all flu strains, including NP and M1. We sought to generate a T cell vaccine broadly protective against all influenza A viruses based on this property. Using Modified Vaccinia Ankara (MVA), we created MVA-NP and MVA-M1 vectors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
